Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Suzuken Co ( (JP:9987) ) is now available.
Suzuken Co., Ltd. announced the results of its share repurchase program for August 2025, acquiring 491,400 common shares for approximately ¥2.87 billion through market purchases on the Tokyo Stock Exchange. This repurchase is part of a larger plan to buy back up to 5.2 million shares, representing 7.21% of total shares outstanding, by March 2026, which may impact the company’s stock value and shareholder equity.
The most recent analyst rating on (JP:9987) stock is a Hold with a Yen6387.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. operates in the pharmaceutical industry, focusing on the distribution of medical products and services. The company is publicly traded on the Tokyo, Nagoya, and Sapporo Stock Exchanges.
YTD Price Performance: 24.37%
Average Trading Volume: 182,580
Technical Sentiment Signal: Buy
Current Market Cap: Yen331.1B
Find detailed analytics on 9987 stock on TipRanks’ Stock Analysis page.